Health
New ‘SINT1A‘ study explores potential of a probiotic to prevent type 1 diabetes in children – News-Medical.Net
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until…
Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘ study explores the potential of a specific probiotic to strengthen the immune system early-on in children with increased genetic risk of type 1 diabetes, and thus prevent its development.
SINT1A is led by Helmholtz Zentrum Muenchen, and part of the…
-
Noosa News19 hours agoProtest calls for shark net removal
-
General18 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News21 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General24 hours agoVigils mark Israel attack anniversary, Gaza death toll